
The research organisation ABPI, alongside RAND Europe, has released a ‘snapshot’ of data, from its Disclosure UK database, from January …
Leading UK contract analytical chemistry provider, Butterworth Laboratories Ltd, is delighted to announce it has secured an additional facility in …

Researchers from the University of Bristol and NHS Blood and Transplant have managed to perfect a technique whereby it is …

Bone Therapeutics, a bone cell therapy company focusing on orthopaedics and bone disease, has appointed Miguel Forte to the position …

Following on from the positive opinion given to Xeljanz in January of this year, Pfizer’s drug has now been given …

Infectex, a Russian portfolio company of Maxwell Biotech Venture Fund, announced that it had found positive results from its latest …

AstraZeneca has been boosted by the news that its drug, Tagrisso, has become its first drug to be approved under …

One million people die from fake drugs every year, with the worst continent being Africa where a suspected 200,000 die …

Merck KGaA and Pfizer have won approval for the fourth immunotherapy treatment to enter the market, with an indication in …

Eli Lilly’s latest press release indicated that it would be spending $850 million in developing its worldwide US operations, particularly …

With the weekend on the horizon and a new issue of Pharmafocus hitting press, we review the most read, shared …

Cancer Research UK has revealed a £10 million investment into PRECISION-Panc, a pancreatic cancer-focused project which aims to improve patient …

This report provides an analysis of the Australian pharmaceutical and biopharmaceutical industry through the lens of patents. By using the …

A new study has emerged that reveals another clue into the process of ageing and how, on a cellular level, …

According to reports emerging, Sanofi may be on the verge of closing a deal with Burlington-based biotech, Flexion Therapeutics. The …

DrugDev has announced the appointment of George Masoura who has joined the company as Vice President, Business Development, Europe to …

It has been reported that Advent International Corp has pulled out of bidding for Pfizer’s stake in Brazilian generics manufacturer, …

New data released by intelligence firm MarketsandMarkets indicates that the global injectable drug market is set to reach $625 billion …

The annual review of drug prices will see the price of drugs, on the National List of Essential Medicines, increase …

GlaxoSmithKline and Regeneron Pharmaceuticals are to band together in a joint effort with UK Biobank – “the world’s most detailed …